ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Geriatric Medicine

Top Geriatric Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KATHLEEN OSHEA-WILK MD

Geriatric Medicine

3,481

$169K

211
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $58

VEERA RAO MD

Geriatric Medicine

645

$22.8K

38
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$35
Average prescription price

Avg: $58

PEYMAN PAHLAVAN M.D.

Geriatric Medicine

5,870

$308K

201
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $58

MARK TRAVIS MD

Geriatric Medicine

3,102

$138K

134
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

DAVID PFOHL MD, FACP, GAQ

Geriatric Medicine

6,012

$297K

300
264 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $58

JAMES KLINE M.D.

Geriatric Medicine

1,295

$76K

131
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

KAREN SCANDRETT MD

Geriatric Medicine

842

$90.1K

30
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$107
Average prescription price

Avg: $58

RACHEL MAYORGA MD

Geriatric Medicine

7,216

$372K

417
379 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $58

ALA ALBAZZAZ M.D.

Geriatric Medicine

4,694

$254K

403
293 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $58

PATRICIA RUSH M.D.

Geriatric Medicine

3,545

$185K

237
219 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $58

ROBERT VACEK M.D.

Geriatric Medicine

3,682

$236K

262
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $58

DAVID WILK MD

Geriatric Medicine

4,501

$249K

236
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $58

DONALD JURIVICH

Geriatric Medicine

3,379

$177K

95
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $58

JENNIFER MANEJA MD

Geriatric Medicine

6,964

$349K

260
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $58

BURAK GEZEN M.D.

Geriatric Medicine

540

$24.9K

92
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

36%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $58

THEODORE CHRISTOU M.D.

Geriatric Medicine

7,196

$433K

354
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $58

NEELIMA SUNKARA M.D

Geriatric Medicine

1,585

$77.7K

145
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $58

KENNETH GRUMET M.D.

Geriatric Medicine

2,978

$194K

307
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $58

BEATA STYKA M.D.

Geriatric Medicine

7,778

$574K

343
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $58

GERALDINE LUNA

Geriatric Medicine

1,787

$154K

180
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$86
Average prescription price

Avg: $58

JAMES KOEPSELL M.D.

Geriatric Medicine

8,014

$433K

338
277 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $58

PATRICIA MERWICK M.D.

Geriatric Medicine

7,936

$468K

460
423 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

BRENT CUTRO DO

Geriatric Medicine

1,282

$57.5K

152
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $58

PAUL NASILOWSKI M.D

Geriatric Medicine

802

$33.8K

55
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $58

AHMAD FAROOQ M.D., M.S.H.S.

Geriatric Medicine

5,139

$206K

167
148 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank